Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) Results in Higher Remission Rates over Conventional 7+3 Chemotherapy without Increased Toxicity in Newly Diagnosed Acute Myeloid Leukemia

Benjamin J. Lee, Shawn P. Griffin, Jean Doh, Stefan O. Ciurea, Piyanuch Kongtim, Deepa Jeyakumar, Kiran Naqvi

Blood (2024) 144 (Supplement 1): 1517.

https://doi.org/10.1182/blood-2024-202856

Published: 2024

Journal Articles

Fludarabine-Melphalan with Total Body Irradiation or with Thiotepa Conditioning for Adult Patients with Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation

Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Kiran Naqvi, Benjamin Lee, Jean Doh, Shawn P. Griffin, Jeffrey Kuo, Jeremy Harris, Piyanuch Kongtim, Stefan O. Ciurea

Blood (2024) 144 (Supplement 1): 7307.

https://doi.org/10.1182/blood-2024-201752

Published: 2024

Journal Articles

Final Results of a Prospective Observational Study Using Budesonide, Added to Ptcy-Based Gvhd Prophylaxis, for Prevention of Acute GI Gvhd after Allogeneic Transplantation

Piyanuch Kongtim, Piyatida Chumnumsiriwath, Pongthep Vittayawacharin, Deepa Jeyakumar, Benjamin Lee, Jean Doh, Shawn P. Griffin, Richard Van Etten, Stefan O. Ciurea

Blood (2024) 144 (Supplement 1): 4908.

https://doi.org/10.1182/blood-2024-202468

Published: 2024

Journal Articles

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

Pongthep Vittayawacharin, Deepa Jeyakumar, Benjamin J. Lee, Jean Doh, Shawn Griffin, Richard A. Van Etten, Piyanuch Kongtim, Stefan Ciurea

Blood (2023) 142 (Supplement 1): 2192.

https://doi.org/10.1182/blood-2023-190530

Published: 2023

Journal Articles

An Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms

Eli M Soyfer, Jane H Chen, Piyanuch Kongtim, Angela G. Fleischman

Blood (2023) 142 (Supplement 1): 6443.

https://doi.org/10.1182/blood-2023-187912

Published: 2023

Journal Articles

Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)

Piyanuch Kongtim, Mary-Elizabeth M. Percival, Timothy J Martins, Guangrong Qin, Niall Curley, Kelda M. Gardner, Sylvia Chien, Jin Dai, Vivian G. Oehler, C. Anthony Blau, Paul C. Hendrie, Ryan D. Cassaday, Anna B. Halpern, Bart L. Scott, Roland B. Walter, Heather Smith, Guido Marcucci, Pamela S. Becker

Blood (2022) 140 (Supplement 1): 1200–1202.

https://doi.org/10.1182/blood-2022-165801

Published: 2022

Journal Articles

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Ashish S Kothari, Nishant Dwivedi, Camila Egidio, Mingwei Fei, Allison Bell, Piyanuch Kongtim, Marica Grskovic, Stefan Ciurea

Blood (2022) 140 (Supplement 1): 13005–13006.

https://doi.org/10.1182/blood-2022-170443

Published: 2022

Journal Articles

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Stefan O. Ciurea, MD, Jolie Schafer, Piyanuch Kongtim, MD, Julianne Chen, Doris Soebbing, Kai Cao, MS, MD, Samer A. Srour, MD MS, Elizabeth J. Shpall, MD, Marina Konopleva, MD PhD, Dean Anthony Lee, MD PhD, Richard E. Champlin, MD

Blood (2020) 136 (Supplement 1): 11–12.

https://doi.org/10.1182/blood-2020-134858

Published: 2020

Journal Articles

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Stefan O. Ciurea, Piyanuch Kongtim, Ankur Varma, Gabriela Rondon, Julianne Chen, Samer Srour, Qaiser Bashir, Amin Alousi, Rohtesh Mehta, Betul Oran, Uday Popat, Chitra Hosing, Amanda Olson, Naval Daver, Marina Konopleva, Richard E. Champlin

Blood (2020) 135 (6): 449–452.

https://doi.org/10.1182/blood.2019003662

Published: 2020

Includes: Supplemental data

Journal Articles

Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis

Stefan O. Ciurea, MD, Ankur Varma, MD, Piyanuch Kongtim, MD, Samer Srour, Qaiser Bashir, MBBS, Amin M. Alousi, MD, Rohtesh S. Mehta, MD, Betul Oran, MDMS, Uday Popat, MD, Chitra Hosing, MD, Gabriela Rondon, MD, Julianne Chen, Amanda L. Olson, MD, Marina Y Konopleva, MD PhD, Richard E Champlin

Blood (2019) 134 (Supplement_1): 42.

https://doi.org/10.1182/blood-2019-123699

Published: 2019

Journal Articles

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

Piyanuch Kongtim, MD, Kotchanut Litlueangdet, Darunee Emrat, MD BSc, Dhosaporn Charoenjit, MD, Supawee Saengboon, MD, Wasithep Limvorapitak, MD, Nonglak Kanitsap, MD, Hataiwan Ratanabunjerdkul, MD

Blood (2019) 134 (Supplement_1): 2421.

https://doi.org/10.1182/blood-2019-123682

Published: 2019

Journal Articles

Is a Matched Unrelated Donor Search Needed for All Allogeneic Transplant Candidates?

Blood (2018) 132 (Supplement 1): 3450.

https://doi.org/10.1182/blood-2018-99-111606

Published: 2018

Journal Articles

Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes

Piyanuch Kongtim, MD, Simrit Parmar, MBBS, Denái R. Milton, Jorge M. Ramos Perez, MD, Gabriela Rondon, MD, Julianne Chen, Abhishek R Chilkulwar, Gheath Alatrash, DO, PhD, Amin M. Alousi, MD, Borje S Andersson, MD PhD, Jin S Im, MD PhD, Chitra Hosing, MD, Qaiser Bashir, MD MBBS, Issa F. Khouri, Partow Kebriaei, MD, Betul Oran, MD MS, Uday Popat, MD, Richard E Champlin, MD, Stefan O. Ciurea

Blood (2018) 132 (Supplement 1): 2141.

https://doi.org/10.1182/blood-2018-99-111639

Published: 2018

Journal Articles

Incidence, Characteristics and Outcomes of Patients with Cancer-Associated Venous Thromboembolism: A Retrospective Matched-Pair Analysis

Piyanuch Kongtim, MD, Dhosaporn Charoenjit, MD, Supawee Saengboon, MD, Hataiwan Ratanabunjerdkul, MD

Blood (2018) 132 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2018-99-113420

Published: 2018

Journal Articles

Validation of a Predictive Model for Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving Hematopoietic Stem Cell Transplantation

Piyanuch Kongtim, MD, Simrit Parmar, MBBS, Denái R. Milton, Gabriela Rondon, MD, Julianne Chen, Betul Oran, MDMS, Uday Popat, MD, Chitra Hosing, Qaiser Bashir, MD MBBS, Partow Kebriaei, MD, Issa F. Khouri, Richard E. Champlin, MD, Stefan O. Ciurea

Blood (2017) 130 (Supplement 1): 4511.

https://doi.org/10.1182/blood.V130.Suppl_1.4511.4511

Published: 2017

Journal Articles

Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation

Blood (2017) 129 (22): 3031–3033.

https://doi.org/10.1182/blood-2017-02-766154

Published: 2017

Includes: Supplemental data

Journal Articles

Haploidentical Donors in Addition to Transplantation in Chronic Phase Associate with Improved Gvhd-Free Relapse-Free Survival (GRFS) for Patients with Advanced CML

Piyanuch Kongtim, MD, Kehinde U. A. Adekola, M.B.B.S, Denái R. Milton, Reshma Ramlal, MD, Antonio M. Jimenez, MD, Julianne Chen, Gabriela Rondon, MD, Sairah Ahmed, MD, Betul Oran, MD, Uday R. Popat, MD, Jorge Cortes, MD, Richard E. Champlin, MD, Stefan O. Ciurea, MD

Blood (2016) 128 (22): 4583.

https://doi.org/10.1182/blood.V128.22.4583.4583

Published: 2016

Journal Articles

Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myelogenous Leukemia (AML) with Complex Karyotypes (CK): A Retrospective Study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT) and MD Anderson Cancer Center (MDACC)

Stefan O. Ciurea, MD, Myriam Labopin, MD, Emmanuelle Polge, Piyanuch Kongtim, MD, Gabriela Rondon, MD, Gerard Socie, MD PhD, Liisa Volin, MD PhD, Jakob R Passweg, MD, Patrice Chevallier, MD PhD, Dietrich W. Beelen, Prof. Dr. MD, Stéphane Vigouroux, MD, Didier Blaise, MD PhD, Jan J. Cornelissen, MD PhD, Nathalie Fegueux, MD, Mohamad Mohty, MD PhD, Bipin N. Savani, MD, Richard E. Champlin, MD, Arnon Nagler

Blood (2016) 128 (22): 3479.

https://doi.org/10.1182/blood.V128.22.3479.3479

Published: 2016

Journal Articles

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Survival for Patients with Chronic Myelomonocytic Leukemia

Blood (2015) 126 (23): 4347.

https://doi.org/10.1182/blood.V126.23.4347.4347

Published: 2015

Journal Articles

Should a Personalized Approach be Also Applied to Hematopoietic Stem-Cell Transplantation (HSCT)? Transplantation for Older Patients with Hematologic Malignancies Suggests so

Stefan O. Ciurea, MD, Piyanuch Kongtim, MD, Gabriela Rondon, MD, Julianne Chen, Richard E. Champlin

Blood (2014) 124 (21): 3875.

https://doi.org/10.1182/blood.V124.21.3875.3875

Published: 2014

NARROW

Venetoclax Combined with Cladribine, Idarubicin, Cytarabine (CLIA) Results in Higher Remission Rates over Conventional 7+3 Chemotherapy without Increased Toxicity in Newly Diagnosed Acute Myeloid Leukemia

Fludarabine-Melphalan with Total Body Irradiation or with Thiotepa Conditioning for Adult Patients with Acute Lymphoblastic Leukemia Receiving Allogeneic Stem Cell Transplantation

Final Results of a Prospective Observational Study Using Budesonide, Added to Ptcy-Based Gvhd Prophylaxis, for Prevention of Acute GI Gvhd after Allogeneic Transplantation

Budesonide Added to Post-Transplantation Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for Prevention of Graft-Versus-Host Disease

An Optimal Dose Finding Study of N-Acetylcysteine in Patients with Myeloproliferative Neoplasms

Long-Term Outcomes of a Clinical Trial of Molecular and Functional Drug Screening for Individualized Therapy in Relapsed and Refractory (R/R) Acute Leukemia (AL)

Acrobat: A Multicenter Prospective Study to Monitor Chimerism in Post Allogeneic Hemopoietic Cell Transplant Patients with AML, ALL, or MDS for Prediction of Engraftment and Relapse

Haploidentical Mbil-21 Ex Vivo Expanded NK Cells (FC21-NK) for Patients with Multiple Relapsed and Refractory Acute Myeloid Leukemia

Is there an optimal conditioning for older patients with AML receiving allogeneic hematopoietic cell transplantation?

Optimal Conditioning for Older Patients with Acute Myeloid Leukemia (AML) Receiving Allogeneic Hematopoietic Stem Cell Transplantation: A Propensity Score Analysis

Development and Validation of a Cancer-Associated Venous Thromboembolism Clinical Risk Prediction (CAT-CR) Model in Newly Diagnosed Cancer Patients Treated with Cheomotherapy

Is a Matched Unrelated Donor Search Needed for All Allogeneic Transplant Candidates?

Hematopoietic Cell Transplant-Composite Risk (HCT-CR) — a Novel Prognostic Model to Predict Transplant Outcomes

Incidence, Characteristics and Outcomes of Patients with Cancer-Associated Venous Thromboembolism: A Retrospective Matched-Pair Analysis

Validation of a Predictive Model for Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome Receiving Hematopoietic Stem Cell Transplantation

Predictive model for survival in patients with AML/MDS receiving haploidentical stem cell transplantation

Haploidentical Donors in Addition to Transplantation in Chronic Phase Associate with Improved Gvhd-Free Relapse-Free Survival (GRFS) for Patients with Advanced CML

Treatment with Hypomethylating Agents before Allogeneic Stem Cell Transplant Improves Survival for Patients with Chronic Myelomonocytic Leukemia

Should a Personalized Approach be Also Applied to Hematopoietic Stem-Cell Transplantation (HSCT)? Transplantation for Older Patients with Hematologic Malignancies Suggests so

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only